Federal 340B Drug Pricing Program – An Industry Update and Mitigation Strategies Relative to Recent Challenges
Omnicell
JANUARY 10, 2023
Jeff Spencer Senior Director, 340B Sales and Account Management, Omnicell Since its inception 30 years ago, the 340B Drug Pricing Program has helped non-profit healthcare organizations expand services for their communities. Before 2018, the reimbursement level was Average Sales Price (ASP) was more than plus 6 percent.
Let's personalize your content